Latest News and Press Releases

RALEIGH, N.C., Feb. 27, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that Howard Doran, President and Chief Executive Officer, and Lucy Martindale, Executive Vice President...

RALEIGH, N.C., Feb. 24, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that it will release its fourth quarter and fiscal year 2013 financial results after the market close...

RALEIGH, N.C., Jan. 22, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced the appointment of Howard Doran to the position of President and Chief Executive Officer and as a...

RALEIGH, N.C., Nov. 27, 2013 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that Bob Greczyn, Interim President and Chief Executive Officer, and Lucy Martindale, Executive Vice...

RALEIGH, N.C., Nov. 21, 2013 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that it will discuss revenue guidance for 2014 on the Company's Fourth Quarter 2013 conference call...

Third Quarter 2013 NMR LipoProfile® Test Volumes Up 3.8% from 2012 Period Third Quarter 2013 Revenue at $12.7 Million Down 6.1% from 2012 Period Company Narrows Revenue Guidance for...

RALEIGH, N.C., Oct. 22, 2013 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that it will release its third quarter of fiscal year 2013 financial results after the market close on...

RALEIGH, N.C., Aug. 8, 2013 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that two new members have recently joined the Board of Directors, Jeffrey T. Barber and James R. ("Bob")...

Second Quarter 2013 NMR LipoProfile® Test Volumes Up 7.5% from 2012 Period Second Quarter 2013 Revenue within Guidance Range at $13.3 Million Down 4.2% from 2012 Period Company Revises...

Company Reports Preliminary Revenues for Second Quarter in Line With Previous Guidance Company Revises Revenue Guidance for Calendar Year 2013 to Between $52 and $54 Million RALEIGH, N.C., Aug,...